{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T02:41:08Z","timestamp":1653446468229},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s42000-022-00353-2","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T05:06:21Z","timestamp":1643691981000},"page":"261-270","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism"],"prefix":"10.1007","volume":"21","author":[{"given":"Emir","family":"Muzurovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin Zibar","family":"Tom\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sne\u017eana","family":"Vujo\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Petakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000181253","volume":"32","author":"M Paillard","year":"1989","unstructured":"Paillard M, Gardin JP, Borensztein P, Prigent A (1989) Determinants of parathormone secretion in primary hyperparathyroidism. Horm Res 32:89\u201392. https:\/\/doi.org\/10.1159\/000181253","journal-title":"Horm Res"},{"key":"353_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE (2018) Hyperparathyroidism Lancet 391:168\u2013178. https:\/\/doi.org\/10.1016\/S0140-6736(17)31430-7","journal-title":"Hyperparathyroidism Lancet"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/00365519209090122","volume":"52","author":"HA S\u00f8rensen","year":"1992","unstructured":"S\u00f8rensen HA, Schwarz P, McNair P, Hyldstrup L, Transb\u00f8l I (1992) Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism. Scand J Clin Lab Invest 52:457\u2013465. https:\/\/doi.org\/10.3109\/00365519209090122","journal-title":"Scand J Clin Lab Invest"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2265.1991.tb03493.x","volume":"35","author":"P Lips","year":"1991","unstructured":"Lips P, Netelenbos JC, van Doorn L, Hackeng WH, Lips CJ (1991) Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients. Clin Endocrinol (Oxf) 35:35\u201340. https:\/\/doi.org\/10.1111\/j.1365-2265.1991.tb03493.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00223-008-9191-9","volume":"83","author":"P Hagag","year":"2008","unstructured":"Hagag P, Kummer E, Weiss M (2008) Primary hyperparathyroidism: role of the preoperative oral calcium loading test in the differential diagnosis between adenoma and hyperplasia. Calcif Tissue Int 83:404\u2013413. https:\/\/doi.org\/10.1007\/s00223-008-9191-9","journal-title":"Calcif Tissue Int"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1210\/jcem-49-2-223","volume":"49","author":"JG Parthemore","year":"1979","unstructured":"Parthemore JG, Deftos LJ (1979) Calcitonin secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 49:223\u2013226. https:\/\/doi.org\/10.1210\/jcem-49-2-223","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jcem-37-4-550","volume":"37","author":"VA LiVolsi","year":"1973","unstructured":"LiVolsi VA, Feind CR, LoGerfo P, Tashjian AH Jr (1973) Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism. J Clin Endocrinol Metab 37:550\u2013559. https:\/\/doi.org\/10.1210\/jcem-37-4-550","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00000441-198007000-00002","volume":"280","author":"KL Becker","year":"1980","unstructured":"Becker KL, Silva OL, Wisneski LA, Cyrus J, Snider RH, Moore CF, Higgins GA (1980) Limited calcitonin reserve in hyperparathyroidism. Am J Med Sci 280:11\u201315. https:\/\/doi.org\/10.1097\/00000441-198007000-00002","journal-title":"Am J Med Sci"},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1210\/jcem-63-3-785","volume":"63","author":"RD Tiegs","year":"1986","unstructured":"Tiegs RD, Body JJ, Barta JM, Heath H 3rd (1986) Plasma calcitonin in primary hyperparathyroidism: failure of C-cell response to sustained hypercalcemia. J Clin Endocrinol Metab 63:785\u2013788. https:\/\/doi.org\/10.1210\/jcem-63-3-785","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2265.1981.tb02751.x","volume":"15","author":"GF Mazzuoli","year":"1981","unstructured":"Mazzuoli GF, D\u2019Erasmo E, Scarda A, Mancini D, Minisola S, Alberti LM, Valtorta C (1981) Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism. Clin Endocrinol (Oxf) 15:81\u201386. https:\/\/doi.org\/10.1111\/j.1365-2265.1981.tb02751.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000180309","volume":"23","author":"S Tabolli","year":"1986","unstructured":"Tabolli S, Valtorta C, Bigi F, Minisola S, Mazzuoli GF (1986) Basal and stimulated calcitonin secretion in primary hyperparathyroidism before and after parathyroidectomy. Horm Res 23:142\u2013146. https:\/\/doi.org\/10.1159\/000180309","journal-title":"Horm Res"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000308170","volume":"73","author":"B Conte-Devolx","year":"2010","unstructured":"Conte-Devolx B, Morlet-Barla N, Roux F, Sebag F, Henry JF, Niccoli P (2010) Could primary hyperparathyroidism-related hypercalcemia induce hypercalcitoninemia? Horm Res Paediatr 73:372\u2013375. https:\/\/doi.org\/10.1159\/000308170","journal-title":"Horm Res Paediatr"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1530\/acta.0.0890122","volume":"89","author":"PD Broulik","year":"1978","unstructured":"Broulik PD, Hradec E, Pacovsk\u00fd V (1978) Calcitonin activity of the thyroid gland in primary hyperparathyroidism. Acta Endocrinol (Copenh) 89:122\u2013125. https:\/\/doi.org\/10.1530\/acta.0.0890122","journal-title":"Acta Endocrinol (Copenh)"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1055\/s-0029-1210708","volume":"90","author":"N K\u00fcbler","year":"1987","unstructured":"K\u00fcbler N, Krause U, Wagner PK, Beyer J, Rothmund M (1987) The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism. Exp Clin Endocrinol 90:324\u2013330. https:\/\/doi.org\/10.1055\/s-0029-1210708","journal-title":"Exp Clin Endocrinol"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.4158\/EP-2019-0246","volume":"25","author":"E Castellano","year":"2019","unstructured":"Castellano E, Attanasio R, Latina A, Gennaro M, Boriano A, Borretta G (2019) Increased serum calcitonin in sporadic primary hyperparathyroidism is an uncommon occurrence. Endocr Pract 25:1279\u20131285. https:\/\/doi.org\/10.4158\/EP-2019-0246","journal-title":"Endocr Pract"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1359\/JBMR.051210","volume":"21","author":"M Bevilacqua","year":"2006","unstructured":"Bevilacqua M, Dominguez LJ, Righini V, Valdes V, Vago T, Leopaldi E, Baldi G, Barrella M, Barbagallo M (2006) Dissimilar PTH, gastrin, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, primary hyperparathyroidism, and normal subjects: a useful tool for differential diagnosis. J Bone Miner Res 21:406\u2013412. https:\/\/doi.org\/10.1359\/JBMR.051210","journal-title":"J Bone Miner Res"},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561\u20133569. https:\/\/doi.org\/10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-2265.1992.tb02336.x","volume":"37","author":"P Schwarz","year":"1992","unstructured":"Schwarz P, S\u00f8rensen HA, Momsen G, McNair P, Transb\u00f8l I (1992) Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study. Clin Endocrinol (Oxf) 37:344\u2013348. https:\/\/doi.org\/10.1111\/j.1365-2265.1992.tb02336.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1210\/jcem.85.12.7028","volume":"85","author":"F Cetani","year":"2000","unstructured":"Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, Pardi E, Viacava P, Naccarato AG, Miccoli P, Kifor O, Brown EM, Pinchera A, Marcocci C (2000) Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85:4789\u20134794. https:\/\/doi.org\/10.1210\/jcem.85.12.7028","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF03345184","volume":"26","author":"S Ortolani","year":"2003","unstructured":"Ortolani S, Scotti A, Cherubini R (2003) Rapid suppression of bone resorption and parathyroid hormone secretion by acute oral administration of calcium in healthy adult men. J Endocrinol Invest 26:353\u2013358. https:\/\/doi.org\/10.1007\/BF03345184","journal-title":"J Endocrinol Invest"},{"key":"353_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2265.2000.00933.x","volume":"52","author":"S Corbetta","year":"2000","unstructured":"Corbetta S, Mantovani G, Lania A, Borgato S, Vicentini L, Beretta E, Faglia G, Di Blasio AM, Spada A (2000) Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia. Clin Endocrinol (Oxf) 52:339\u2013348. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00933.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/cen.12729","volume":"82","author":"A Cailleux","year":"2015","unstructured":"Cailleux A, Vuillermet P, Basuyau JP, M\u00e9nard JF, Lefebvre H, Kuhn JM, Pr\u00e9vost G (2015) A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study Clin Endocrinol (Oxf) 82:663\u2013669. https:\/\/doi.org\/10.1111\/cen.12729","journal-title":"A pilot study Clin Endocrinol (Oxf)"},{"key":"353_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.0954-6820.1981.tb09769.x","volume":"210","author":"T B\u00f8rresen","year":"1981","unstructured":"B\u00f8rresen T, J\u00f8rgensen FS, Transb\u00f8l I, Madsen SN (1981) Influence of calcium infusion on urinary cyclic AMP and phosphate in hyperparathyroidism. Acta Med Scand 210:15\u201319. https:\/\/doi.org\/10.1111\/j.0954-6820.1981.tb09769.x","journal-title":"Acta Med Scand"},{"key":"353_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/jcem-46-3-477","volume":"46","author":"AE Broadus","year":"1978","unstructured":"Broadus AE, Deftos LJ, Bartter FC (1978) Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test. J Clin Endocrinol Metab 46:477\u2013487. https:\/\/doi.org\/10.1210\/jcem-46-3-477","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.0954-6820.1973.tb10586.x","volume":"193","author":"L Mosekilde","year":"1973","unstructured":"Mosekilde L, Andersen P (1973) The calcium infusion test in primary hyperparathyroidism. Acta Med Scand 193:331\u2013336. https:\/\/doi.org\/10.1111\/j.0954-6820.1973.tb10586.x","journal-title":"Acta Med Scand"},{"key":"353_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1530\/EJE-07-0132","volume":"157","author":"I Titon","year":"2007","unstructured":"Titon I, Cailleux-Bounacer A, Basuyau JP, Lefebvre H, Savour\u00e9 A, Kuhn JM (2007) Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism. Eur J Endocrinol 157:351\u2013357. https:\/\/doi.org\/10.1530\/EJE-07-0132","journal-title":"Eur J Endocrinol"},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.clinbiochem.2011.03.142","volume":"44","author":"L Zhao","year":"2011","unstructured":"Zhao L, Zhang MJ, Zhao HY, Sun LH, Li JL, Tao B, Wang WQ, Ning G, Liu JM (2011) PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism. Clin Biochem 44:844\u2013848. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.03.142","journal-title":"Clin Biochem"},{"key":"353_CR28","first-page":"5445","volume":"7","author":"X Zhu","year":"2014","unstructured":"Zhu X, Shan C, Zhu Q, Song L, Zhou Y, Liu J, Zhang K (2014) Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism. Int J Clin Exp Med 7:5445\u20135452","journal-title":"Int J Clin Exp Med"},{"key":"353_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ckj\/sfv011","volume":"8","author":"AJ Felsenfeld","year":"2015","unstructured":"Felsenfeld AJ, Levine BS (2015) Calcitonin, the forgotten hormone: does it deserve to be forgotten? Clin Kidney J 8:180\u2013187. https:\/\/doi.org\/10.1093\/ckj\/sfv011","journal-title":"Clin Kidney J"},{"key":"353_CR30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1046\/j.1365-2362.2002.01054.x","volume":"32","author":"W Wang","year":"2002","unstructured":"Wang W, Lewin E, Olgaard K (2002) Role of calcitonin in the rapid minute-to-minute regulation of plasma Ca2+ homeostasis in the rat. Eur J Clin Invest 32:674\u2013681. https:\/\/doi.org\/10.1046\/j.1365-2362.2002.01054.x","journal-title":"Eur J Clin Invest"},{"key":"353_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0303-7207(89)90103-2","volume":"63","author":"H Scher\u00fcbl","year":"1989","unstructured":"Scher\u00fcbl H, Raue F, Zopf G, Hoffmann J, Ziegler R (1989) Reversible desensitization of calcitonin secretion by repetitive stimulation with calcium. Mol Cell Endocrinol 63:263\u2013266. https:\/\/doi.org\/10.1016\/0303-7207(89)90103-2","journal-title":"Mol Cell Endocrinol"},{"key":"353_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1530\/acta.0.1080372","volume":"108","author":"O T\u00f8rring","year":"1985","unstructured":"T\u00f8rring O, Bucht E, Sj\u00f6berg HE (1985) Decreased plasma calcitonin response to a calcium clamp in primary hyperparathyroidism. Acta Endocrinol (Copenh) 108:372\u2013376. https:\/\/doi.org\/10.1530\/acta.0.1080372","journal-title":"Acta Endocrinol (Copenh)"},{"key":"353_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1172\/JCI109342","volume":"63","author":"PW Lambert","year":"1979","unstructured":"Lambert PW, Heath H 3rd, Sizemore GW (1979) Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism. J Clin Invest 63:602\u2013608. https:\/\/doi.org\/10.1172\/JCI109342","journal-title":"J Clin Invest"},{"key":"353_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/ki.1991.263","volume":"40","author":"A Torres","year":"1991","unstructured":"Torres A, Rodriguez M, Felsenfeld A, Martin-Malo A, Llach F (1991) Sigmoidal relationship between calcitonin and calcium: studies in normal, parathyroidectomized, and azotemic rats. Kidney Int 40:700\u2013704. https:\/\/doi.org\/10.1038\/ki.1991.263","journal-title":"Kidney Int"},{"key":"353_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/nu9030241","volume":"9","author":"A Lotito","year":"2017","unstructured":"Lotito A, Teramoto M, Cheung M, Becker K, Sukumar D (2017) Serum parathyroid hormone responses to vitamin D supplementation in overweight\/obese adults: a systematic review and meta-analysis of randomized clinical trials. Nutrients 9:241. https:\/\/doi.org\/10.3390\/nu9030241","journal-title":"Nutrients"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00353-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-022-00353-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00353-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T02:19:27Z","timestamp":1653445167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-022-00353-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s42000-022-00353-2","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"31 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Scientific Committee of the University of Montenegro (Faculty of Medicine\/Clinical Center of Montenegro).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}